Back to COVID and Long COVID

Research Roundtable with Dr. Jim Heath on COVID

Events Infectious Disease COVID and Long COVID Heath Lab Research Roundtable

On January 18, 2022, Dr. Jim Heath gave a talk on COVID at the first Research Roundtable event of 2022. Research Roundtable is a series of ISB hosted conversations with our leading scientists on the latest research happening at ISB. Designed for a lay audience, this series is open to all. Attendees have the opportunity to ask questions directly to our scientists.

screenshot of video for Research Roundtable with Dr. Jim Heath on COVID

On January 18, 2022, Dr. Jim Heath gave a talk on COVID at the first Research Roundtable event of 2022. Research Roundtable is a series of ISB hosted conversations with our leading scientists on the latest research happening at ISB. Designed for a lay audience, this series is open to all. Attendees have the opportunity to ask questions directly to our scientists.

Related Content

screenshot of virtual video call

Posted:

Chronic Illness Press Release Heath Lab Autoimmune Diseases
Common Immune Response Protective Across Many Diseases

Common Immune Response Protective Across Many Diseases

Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.

Common Immune Response Protective Across Many Diseases
Common Immune Response Protective Across Many Diseases
screenshot of video for Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses

Posted:

Cancer Events Press Release Heath Lab Precision Treatments Research Roundtable
Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses

Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses

In a breakthrough discovery that changes how we understand T cells and with implications of how we can better engineer custom immune responses to fight disease, Institute for Systems Biology researchers showed that the different disease-fighting functions of different T cells are determined by the genetically encoded T-cell receptor sequence that are unique to those cells.

Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses
Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses
screenshot of video for Heath PACT

Posted:

Cancer Press Release Heath Lab Precision Treatments Understanding Tumors
How Immune Cells ‘See’ and Respond to Mutations in Cancer Cells

How Immune Cells ‘See’ and Respond to Mutations in Cancer Cells

In a just-published paper in the journal Nature, a collaborative team of researchers from ISB, UCLA, PACT Pharma, and beyond analyzed T-cell responses in melanoma patients who were treated with different immune checkpoint inhibitors, and how those responses evolved over time.

How Immune Cells ‘See’ and Respond to Mutations in Cancer Cells
How Immune Cells ‘See’ and Respond to Mutations in Cancer Cells